Latest Updates
Supercharging flu vaccine for vulnerable Australians
Clinical trial to test benefits of fibre supplement to enhance flu vaccine.
Vaccine patch trial success
Vaxxas’ micro-needle patch demonstrated significantly enhanced immune response compared to vaccination by needle/syringe.
Source of inflammation found for Rheumatoid arthritis
Researchers find new details about how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack.
An Australian-first initiative of 'bench to bedside' medical research
The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.
The work conducted at TRI is translational research, a research process which involves teams of patients, clinicians and researchers working together to solve health challenges faster. The work is driven by the needs of patients, a question formed by a clinician and a solution sought by a scientist.
What is Translational Research?
Also known as 'bench-to-bedside' research, it is a type of medical research that focusses on 'translating' basic science discoveries from the laboratory into the clinic.
The aim is to improve how we detect, diagnose and treat health conditions, and improve health outcomes for patients.
At TRI, we work to develop new treatments and diagnostics for conditions ranging from various cancers to autoimmune diseases, and translate these discoveries into improved healthcare.
